RFA-NS-21-022 - Translational Neural Devices (U44 Clinical Trial Optional)
PAR-21-282 - Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
December 20, 2022
The purpose of this notice is to inform interested applicants of a change in the expiration date and cancellation of the final four receipt dates for RFA-NS-21-022 "Translational Neural Devices (U44 Clinical Trial Optional)." Effective immediately, the February 21, 2023; June 19, 2023; October 18, 2023; and February 20, 2024 receipt dates have been eliminated, and the new expiration date for this Funding Opportunity Announcement will be January 6, 2023 (earlier than previously published). Potential applicants should consider the Blueprint MedTech Small Business Translator opportunity (PAR-21-282) as an alternative and discuss their application with program staff at the email below to determine fit for this or other opportunities.
Changes to the Key Dates section are shown below.
Part. 1 Overview Information
Key Dates
Currently Reads:
Application Due Date(s) July 1, 2021;October 20, 2021; February 18, 2022; June 20, 2022; October 18, 2022; February 21, 2023; June 19, 2023; October 18, 2023; February 20, 2024
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s) Not Applicable
Scientific Merit Review November 2021, March 2022, July 2022, November 2022, March 2023, July 2023, November 2023, March 2024, July 2024
Advisory Council Review January 2022, May 2022, October 2022, January 2023, May 2023, October 2023, January 2024, May 2024, October 2024
Earliest Start Date March 2022; July 2022; November 2022; March 2023; July 2023; November 2023; March 2024; July 2024; November 2024
Expiration Date February 21, 2024
Modified to Read:
Application Due Date(s) July 1, 2021;October 20, 2021; February 18, 2022; June 20, 2022; October 18, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s) Not Applicable
Scientific Merit Review November 2021, March 2022, July 2022, November 2022, March 2023
Advisory Council Review January 2022, May 2022, October 2022, January 2023, May 2023
Earliest Start Date March 2022; July 2022; November 2022; March 2023; July 2023
Expiration Date December 20, 2022
No other changes to this announcement.
Nick Langhals, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
E-mail: [email protected]
and Human Services (HHS)
